NASDAQ:CMPX

Compass Therapeutics Stock Predictions

etoro logo Buy CMPX
*Your capital is at risk
$2.10
+0.0200 (+0.96%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

CMPX Prediction Chart

CMPX Predictions History

Latest community submissions for CMPX.
Predictor Target Session Target Price Result Direction Accuracy Score
Oct 6, 2025 $3.65 -1.48% $3.67 V 99.33% 4
Oct 6, 2025 Bullish $3.67 V 0
Aug 13, 2025 $3.11 -1.83% $3.17 X 98.17% 0
Aug 13, 2025 Bullish $3.17 X 0
Aug 13, 2025 $3.34 +0.00% $3.17 V 94.64% 0
Jul 28, 2025 $3.11 -2.36% $3.20 X 97.03% 0
Jul 28, 2025 $3.13 -1.47% $3.20 X 97.91% 0
Jul 28, 2025 Bullish $3.20 V 1
Jul 28, 2025 Bullish $3.20 V 1
Apr 8, 2025 $1.68 +7.04% $1.59 V 94.30% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CMPX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT COMPASS THERAPEUTICS, INC.
Compass Therapeutics
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, develops proprietary antibody-based therapeutics to treat multiple human diseases. The company's product candidates include CTX-009, an investigational bispecific antibody, which is in Phase II clinical trial for biliary tract cancers, as well as Phase Ib clinical trial for colorectal and ovarian cancer; CTX-471, a monoclonal antibody product candidate that i...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE